Implementing Adaptive Designs in Rare Disease Clinical Trials
Implementing Adaptive Designs in Rare Disease Clinical Trials How Adaptive Designs Enhance Rare Disease Clinical Trial Efficiency Why Adaptive Designs Are Ideal for Rare Disease Trials Traditional randomized controlled trials (RCTs) often face feasibility issues in rare disease drug development due to small patient populations, recruitment difficulties, and ethical concerns over placebo use. Adaptive designs—clinical…
Read More “Implementing Adaptive Designs in Rare Disease Clinical Trials” »